Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0HX1T
|
||||
Former ID |
DIB009916
|
||||
Drug Name |
DA-697b
|
||||
Synonyms |
DZ-697b; Oral anticoagulants, Daiichi
|
||||
Indication | Thrombosis [ICD9: 437.6, 453, 671.5, 671.9; ICD10:I80-I82] | Phase 1 | [530630] | ||
Company |
Daiichi Seiyaku Co Ltd
|
||||
Target and Pathway | |||||
Target(s) | Von Willebrand factor | Target Info | Inhibitor | [530630] | |
Reactome | Platelet degranulation | ||||
Intrinsic Pathway of Fibrin Clot Formation | |||||
Integrin cell surface interactions | |||||
Integrin alphaIIb beta3 signaling | |||||
GRB2:SOS provides linkage to MAPK signaling for Integrins | |||||
p130Cas linkage to MAPK signaling for integrins | |||||
GP1b-IX-V activation signalling | |||||
MAP2K and MAPK activation | |||||
Platelet Adhesion to exposed collagen | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.